SecBot SecBot
SECBOTREPLAY Home › Report › CYTK

CYTK · Director files 144 for 5K shares

CYTOKINETICS INC · 144 filed Nov 9, 2026 at 16:35 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 9, 2026 at 16:35 ET

Director B. Lynne Parshall filed a Form 144 notice of intent to sell 5,000 shares of Cytokinetics common stock, with an estimated aggregate market value of $268,450. The shares were acquired via restricted stock units vested on May 14, 2026. The sale is planned for execution on or after November 9, 2026, and is part of a 10b5-1 trading plan established on September 1, 2026.

  • Director B. Lynne Parshall intends to sell 5,000 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $268,450.
  • Shares were acquired via restricted stock units that vested on May 14, 2026.
  • The sale is planned for execution on or after November 9, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access